Cargando…

Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma

BACKGROUND: Dendritic cells (DC) are uniquely equipped to capture, process, and present antigens from their environment. The context in which an antigen is acquired by DC helps to dictate the subsequent immune response. Cancer vaccination promotes antitumor immunity by directing an immune response t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pardee, Angela D., Yano, Hiroshi, Weinstein, Aliyah M., Ponce, Aaron A. K., Ethridge, Alexander D., Normolle, Daniel P., Vujanovic, Lazar, Mizejewski, Gerald J., Watkins, Simon C., Butterfield, Lisa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509479/
https://www.ncbi.nlm.nih.gov/pubmed/26199728
http://dx.doi.org/10.1186/s40425-015-0077-x
_version_ 1782382038401155072
author Pardee, Angela D.
Yano, Hiroshi
Weinstein, Aliyah M.
Ponce, Aaron A. K.
Ethridge, Alexander D.
Normolle, Daniel P.
Vujanovic, Lazar
Mizejewski, Gerald J.
Watkins, Simon C.
Butterfield, Lisa H.
author_facet Pardee, Angela D.
Yano, Hiroshi
Weinstein, Aliyah M.
Ponce, Aaron A. K.
Ethridge, Alexander D.
Normolle, Daniel P.
Vujanovic, Lazar
Mizejewski, Gerald J.
Watkins, Simon C.
Butterfield, Lisa H.
author_sort Pardee, Angela D.
collection PubMed
description BACKGROUND: Dendritic cells (DC) are uniquely equipped to capture, process, and present antigens from their environment. The context in which an antigen is acquired by DC helps to dictate the subsequent immune response. Cancer vaccination promotes antitumor immunity by directing an immune response to antigens expressed by tumors. We have tested the tumor-associated antigen alpha-fetoprotein (AFP) as an immunotherapy target. The majority of hepatocellular carcinomas (HCC) upregulate and secrete this oncofetal antigen. METHODS: To develop cancer vaccines for HCC capable of promoting potent tumor-specific T cell responses, we tested adenovirally-encoded synthetic AFP, with or without its signal sequence, as well as protein forms of AFP and compared intracellular routing and subsequent antigen-specific CD8+ and CD4+ T cell responses. RESULTS: Surprisingly, the secreted form of antigen was superior for both CD4+ and CD8+ T cell activation. We also examined the mechanism through which AFP protein is endocytosed and trafficked in human DC. We identify the mannose receptor (MR/CD206) as the primary uptake pathway for both normal cord blood-derived AFP (nAFP) and tumor-derived AFP (tAFP) proteins. While in healthy donors, nAFP and tAFP were cross-presented to CD8+ T cells similarly and CD4+ T cell responses were dependent upon MR-mediated uptake. In HCC patient cells, tAFP was more immunogenic, and CD4+ T cell responses were not MR-dependent. CONCLUSIONS: Secreted, cytoplasmically retained, and endocytosed forms of AFP utilize unique uptake and processing pathways, resulting in different immunologic responses from the induced antigen-specific CD4+ and CD8+ T cells and between healthy donors and HCC patients. Collectively, these data elucidate pathways of spontaneous and induced anti-tumor immunity in HCC patients to this secreted antigen. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40425-015-0077-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4509479
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45094792015-07-22 Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma Pardee, Angela D. Yano, Hiroshi Weinstein, Aliyah M. Ponce, Aaron A. K. Ethridge, Alexander D. Normolle, Daniel P. Vujanovic, Lazar Mizejewski, Gerald J. Watkins, Simon C. Butterfield, Lisa H. J Immunother Cancer Research Article BACKGROUND: Dendritic cells (DC) are uniquely equipped to capture, process, and present antigens from their environment. The context in which an antigen is acquired by DC helps to dictate the subsequent immune response. Cancer vaccination promotes antitumor immunity by directing an immune response to antigens expressed by tumors. We have tested the tumor-associated antigen alpha-fetoprotein (AFP) as an immunotherapy target. The majority of hepatocellular carcinomas (HCC) upregulate and secrete this oncofetal antigen. METHODS: To develop cancer vaccines for HCC capable of promoting potent tumor-specific T cell responses, we tested adenovirally-encoded synthetic AFP, with or without its signal sequence, as well as protein forms of AFP and compared intracellular routing and subsequent antigen-specific CD8+ and CD4+ T cell responses. RESULTS: Surprisingly, the secreted form of antigen was superior for both CD4+ and CD8+ T cell activation. We also examined the mechanism through which AFP protein is endocytosed and trafficked in human DC. We identify the mannose receptor (MR/CD206) as the primary uptake pathway for both normal cord blood-derived AFP (nAFP) and tumor-derived AFP (tAFP) proteins. While in healthy donors, nAFP and tAFP were cross-presented to CD8+ T cells similarly and CD4+ T cell responses were dependent upon MR-mediated uptake. In HCC patient cells, tAFP was more immunogenic, and CD4+ T cell responses were not MR-dependent. CONCLUSIONS: Secreted, cytoplasmically retained, and endocytosed forms of AFP utilize unique uptake and processing pathways, resulting in different immunologic responses from the induced antigen-specific CD4+ and CD8+ T cells and between healthy donors and HCC patients. Collectively, these data elucidate pathways of spontaneous and induced anti-tumor immunity in HCC patients to this secreted antigen. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40425-015-0077-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-21 /pmc/articles/PMC4509479/ /pubmed/26199728 http://dx.doi.org/10.1186/s40425-015-0077-x Text en © Pardee et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pardee, Angela D.
Yano, Hiroshi
Weinstein, Aliyah M.
Ponce, Aaron A. K.
Ethridge, Alexander D.
Normolle, Daniel P.
Vujanovic, Lazar
Mizejewski, Gerald J.
Watkins, Simon C.
Butterfield, Lisa H.
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
title Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
title_full Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
title_fullStr Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
title_full_unstemmed Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
title_short Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
title_sort route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509479/
https://www.ncbi.nlm.nih.gov/pubmed/26199728
http://dx.doi.org/10.1186/s40425-015-0077-x
work_keys_str_mv AT pardeeangelad routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma
AT yanohiroshi routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma
AT weinsteinaliyahm routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma
AT ponceaaronak routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma
AT ethridgealexanderd routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma
AT normolledanielp routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma
AT vujanoviclazar routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma
AT mizejewskigeraldj routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma
AT watkinssimonc routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma
AT butterfieldlisah routeofantigendeliveryimpactstheimmunostimulatoryactivityofdendriticcellbasedvaccinesforhepatocellularcarcinoma